Following the establishment of the tumors, mice were treated with varying doses of LA-CB1 (0.5 mg/kg, 1 mg/kg, and 2 mg/kg) or vehicle control, and bioluminescence imaging was used to monitor tumor growth at Day 1, Day 11, and Day 21 post-xenograft. The gene discussed is CNR1; the disease is neoplasm.